GI Case Conference - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

GI Case Conference

Description:

MMF (cellcept) C diff colitis. Other viral Illnesses. What would you do next? EGD ... for GVHD with high dose steroids, and cyclosporine and MMF were continued ... – PowerPoint PPT presentation

Number of Views:128
Avg rating:3.0/5.0
Slides: 28
Provided by: ystoc
Category:
Tags: case | conference | mmf

less

Transcript and Presenter's Notes

Title: GI Case Conference


1
GI Case Conference
  • Irteza Inayat, MD
  • 02/08/08

2
History
  • 38yo M s/p matched sibling donor (F?M) stem cell
    transplant for recurrent NKT-cell lymphoma
  • GI team was consulted for diarrhea on day 30
    post transplant
  • Onc Hx
  • Presented with left testicular pain in June 2006,
    referred to urology. A left orchiectomy 07/06
    showed NKT-cell lymphoma
  • Treated in 08/06 with HyperCVAD followed by
    consolidation with high-dose BEAM and autologous
    stem cell rescue
  • In 05/07, he had recurrence of his disease and
    was treated with Radiation Therapy
  • In 09/07, complained of decreased vision in his
    right eye? vitreal biopsy confirmed recurrent
    lymphoma
  • Patient underwent a MSD SCTx in 11/07.

3
  • PMHx
  • - DM2
  • PSHx
  • - none
  • Allergies
  • - none
  • SHx
  • - denies tobacco, Etoh, Illicit drug use
  • FHx
  • - non-contributory
  • Medications
  • Lantus
  • Prednisone
  • Tacrolimus
  • MMF (cellcept)
  • Protonix
  • Oxycodone
  • Prochlorperazine
  • Ativan
  • Folic Acid
  • MVI
  • Voriconazole
  • Pentamidine

4
  • HPI
  • Day 30 Post-Transplant
  • Patient complained of loose watery stools 8-10
    BMs/d (Volume1500-1800cc per day). No blood or
    mucous in stools. Not related to eating, included
    nocturnal episodes.
  • Denied any associated abdominal pain/cramping,
    nausea or vomiting. Occasional bloating was
    reported.
  • No fevers, chills, rash, change in his diet
    recently, no recent travel and no prior similar
    complaints
  • No personal or family history of GI disease
  • No hx of jaundice or pruritus
  • No recent changes in medication

5
  • Physical Exam
  • VITALS 98.6ºF 88 127/84 98 RA
  • GEN AO X 3, appears to be uncomfortable
  • HEENT dry mmm, Ø LAN, Ø pallor, anicteric
  • CHEST CTA b
  • CV RRR Ø r/m/g
  • ABD soft bs NT/ND no HSM
  • EXT Ø c/c/e
  • NEURO non-focal
  • Rectal Normal tone, no tenderness, heme negative

6
Labs
111
10.1
142
27
3.9
154
41
3.8
24.1
1.1
29.3
ANC 3.4 Diff normal
INR 1.2 ALB 3.1 LFTs WNL
Tacro 15 BCx neg Amylase/Lipase WNL
7
Labs
  • Stool Studies Other Serologies
  • Stool Cx normal flora CMV Ag (blood) neg
  • Stool WBC neg
  • C Diff toxin neg
  • Rectal swab neg for VRE
  • Rotavirus Ag neg
  • Adenovirus PCR neg
  • Norovirus PCR neg

8
What is the Differential Diagnosis?
9
DDx
  • Preconditioning regimen (mucositis)
  • GVHD
  • CMV infection
  • Cryptosporidum
  • Cyclosporin
  • MMF (cellcept)
  • C diff colitis
  • Other viral Illnesses

What would you do next?
10
  • EGD
  • Small hiatal hernia, otherwise normal appearing
    mucosa, biopsies done
  • Colonoscopy
  • Normal appearing TI and colonic mucosa, biopsies
    done
  • Pathology

11
(No Transcript)
12
(No Transcript)
13
(No Transcript)
14
  • Hospital Course
  • Patient was started on treatment for GVHD with
    high dose steroids, and cyclosporine and MMF were
    continued
  • Repeat stool studies were negative again
  • Pt continued to have 1 liter of stool output
  • Repeat scope pursued on post-transplant day 41

15
  • EGD
  • Normal appearing mucosa, biopsies were done
  • Colonoscopy
  • Edematous and erythematous distal TI mucosa was
    biopsied
  • Mildly erythematous colonic mucosa was also
    biopsied
  • Pathology
  • - CMV ILEITIS WITH ULCERATION
  • IMMUNOSTAIN FOR CMV IS CONFIRMATORY
  • Gastric, duodenal and colonic mucosa without
    significant abnormality
  • Colonic mucosa did not show the features of GVHD
    seen on previous biopsies.

16
  • Hospital Course
  • Reactivated CMV ? Ag () and CMV cells/200,000
    ? 55
  • Ganciclovir was started

17
Hospital Course
  • Repeat stool studies were negative again
  • Patient did not report any change in his symptoms
    during this time with continued diarrhea
  • CMV Ag was negative now
  • GI was consulted again on post-transplant day 60

18
  • Further work up???
  • Colonoscopy
  • Mild erythema of colonic mucosa
  • Edematous and narrowed IC valve, diffusely
    erythematous, friable and hemorrhagic TI mucosa
    with loss of villous pattern

19
(No Transcript)
20
(No Transcript)
21
(No Transcript)
22
(No Transcript)
23
  • Colonic GVHD
  • Whose most at risk?
  • HLA-mismatched donor
  • Unrelated HLA- matched donor
  • Dose of preconditioning regimen
  • F donor?M recipient
  • age
  • CML
  • In a pt with BMT, what is the most common cause
    of diarrhea?
  • 100d ? Infection, Chronic GVHD, Pancreatic
    insufficiency

24
In general, survival and grade of GVHD are
inversely related
How do you gauge severity of GI GVHD?
(Curr Opin in Gastroenterology 2005, 2164-69)
25
  • Diagnosis
  • Apoptosis on a mucosal biopsy is required to make
    a diagnosis of GI GVHD
  • In a series of post-HSCT patients with diarrhea,
    gastric biopsy proved to be the single most
    useful test in establishing a diagnosis of acute
    GVHD in 22 of 26 patients (Gastroenterology 1994,
    1071398-1407)
  • Some studies have shown that small bowel biopsies
    are more fruitful than gastric samples
    (Endoscopy, 1996, 28680-685, Blood 2002,
    993033-3040)
  • Endoscopically normal examinations are reported
    in 18 of GI GVHD patients (Transplantation 1991,
    51642-646)
  • Current recommendation is to biopsy stomach,
    duodenum and rectum routinely when patients are
    referred for evaluation of potential acute GVHD
    (Curr Opin in Gastroenterology 2005, 2164-69)

26
  • CMV enterocolitis
  • Reactivation of CMV following HSCT occurs in
    60-80 of patients
  • CMV enterocolitis is the 2nd most common
    end-organ manifestation
  • Incidence of CMV enteritis at 2 years post-Tx
    averaged 2
  • Median time to diagnosis was 91 days post-Tx
    (range, 17-527 days)
  • Viremia detected in two thirds of patients with
    CMV prior to detection of enteritis
  • Overall survival was 35 at 2 years following the
    onset of eneteritis
  • (Biology of Blood and Marrow Transp 2001,
    7674-679)

27
  • Patient follow up
  • On day 70, diarrhea started to improve with
    decrease in stool frequency and volume
  • Pt was discharged home on ganciclovir, steroid
    taper, cellcept and tacrolimus
  • Diarrhea continues to improve with 2-3 loose
    BMs/day (Volume 300-400cc per day)
Write a Comment
User Comments (0)
About PowerShow.com